- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07661563
Advancing Scalable Alcohol Brief Interventions in the ED: A Trial of Conversational AI With Digital Reinforcements (MICA-ED)
A Randomized Trial of an AI Intervention to Help Individuals With Risky Alcohol Use Among Emergency Department Patients
The goal of this clinical trial is to learn if a novel digital strategy combining a generative AI counseling agent (MICA) and weekly SMS boosters works to reduce risky drinking among Emergency Department patients.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
California
-
Palo Alto, California, États-Unis, 94304
- Recrutement
- Stanford University Medical Center
-
Contact:
- Brian Suffoletto, MD
- Numéro de téléphone: 412-901-6892
- E-mail: suffbp@stanford.edu
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- For men: AUDIT-C score 4+
- For women: AUDIT-C score 3+
- Owns a mobile phone
- Reads English language
Exclusion Criteria:
- For women: current or planned pregnancy in next 12 months
- Prisoner
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: MICA
MICA is a generative AI-powered counseling agent that delivers brief Motivational Interviewing (MI)-consistent sessions, following the validated MI process (engagement, focusing, evoking, planning, and closing). It uses personalized prompts to promote autonomy and evoke change talk, ending with a session summary and satisfaction check. Participants will complete a MICA session (~5-10 min) in the ED and at 3 months. |
MICA is an AI chatbot that uses a secure API with ChatGPT and prompted to follow MI principles to support individuals in exploring and resolving ambivalence about their alcohol use. MICA follows a predefined conversational framework and steps: introduction, engagement, focusing, evoking, planning, and closing-adapted from Miller & Rollnick's Motivational Interviewing: Helping People Change (3rd ed.). |
|
Expérimental: MICA+SMS
This condition includes the MICA ED session, a 3-month booster, and 12 weeks of weekly SMS messages supporting self-monitoring, goal-setting, and adaptive strategies. Messages are tailored based on reported alcohol use and goal commitment, offering encouragement, feedback, and harm-reduction messaging. |
MICA is an AI chatbot that uses a secure API with ChatGPT and prompted to follow MI principles to support individuals in exploring and resolving ambivalence about their alcohol use. MICA follows a predefined conversational framework and steps: introduction, engagement, focusing, evoking, planning, and closing-adapted from Miller & Rollnick's Motivational Interviewing: Helping People Change (3rd ed.). Weekly SMS check-ins designed to support goal-setting, self-monitoring, and adaptive self-regulation strategies. Beginning the Sunday after enrollment, participants will engage with an automated SMS program once weekly for 12 weeks. Prompts include reporting on the past week's alcohol use and whether they are willing to commit to a drinking limit goal for the upcoming week. Responses trigger tailored feedback. |
|
Aucune intervention: Standard care
Standard ED care and as-needed referral to alcohol resources |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Mean weekly alcohol consumption
Délai: Baseline, 3-, 6-, and 12-month follow-ups
|
Participants report (1) the average number of standard alcohol drinks each day of the week. Estimated weekly alcohol consumption will be calculated as the sum of all those drinks over 7 days. |
Baseline, 3-, 6-, and 12-month follow-ups
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Number of heavy drinking days
Délai: Baseline, 3-, 6-, and 12-month follow-ups
|
Asking participants: "Over the past 30 days, how many days did you have 4+ standard drinks (women) / 5+ standard drinks (men)?" |
Baseline, 3-, 6-, and 12-month follow-ups
|
|
Max number of drinks per drinking day
Délai: Baseline, 3-, 6-, and 12-month follow-ups
|
Asking participants, "Over the past 30 days, what is the most drinks you had on any single day?" |
Baseline, 3-, 6-, and 12-month follow-ups
|
|
AUDIT score
Délai: Baseline, 3-, 6, 12-months
|
Alcohol Use Disorders Identification Test (AUDIT) is a 10 question screen for AUD (0-40 Scale; higher numbers indicate higher risk for AUD). |
Baseline, 3-, 6, 12-months
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
SIP-2R
Délai: Baseline, 3-, 6-, and 12-months
|
Short Inventory of Problems (SIP-2R) is a 15-item questionnaire used to measure the negative consequences and harm caused by drinking alcohol. Score 0 to 45 (higher scores indicate more frequent or severe problems) |
Baseline, 3-, 6-, and 12-months
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Brian Suffoletto, MS MS, Stanford University
Publications et liens utiles
Publications générales
- Suffoletto B, Prieksaitis C, Rose C, Kim D, Pillai N, Pitre V. Feasibility and Acceptability of a Large Language Model-Based Motivational Interviewing Agent in the Emergency Department. Ann Emerg Med. 2026 Jan;87(1):121-123. doi: 10.1016/j.annemergmed.2025.08.021. Epub 2025 Oct 2. No abstract available.
- Suffoletto B, Preiksaitis C, Kim D, Rose C, Pitre V, Pillai N, Mandal M. AI counseling agent for motivational interviewing: Conversational processes associated with change talk in emergency department patients. J Subst Use Addict Treat. 2026 Nov;190:210053. doi: 10.1016/j.josat.2026.210053. Epub 2026 Jun 12.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 86953
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
All survey data from baseline through 12-month followups will be uploaded to the data repository (the National Institute on Alcohol Abuse and Alcoholism Data Archive (NIAAADA). All counseling sessions and SMS data will be de-identified and kept in a separate repository.
Délai de partage IPD
Data will be available within 1 year of study completion and available indefinitely.
Critères d'accès au partage IPD
Individuals with appropriate ethical approval and access to the NIAAADA or a DUA with the PI.
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- SÈVE
- ANALYTIC_CODE
- RSE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .